Compare BLLN & KTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLLN | KTB |
|---|---|---|
| Founded | 2016 | 2018 |
| Country | United States | United States |
| Employees | 713 | N/A |
| Industry | Medical Specialities | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.8B |
| IPO Year | N/A | 2018 |
| Metric | BLLN | KTB |
|---|---|---|
| Price | $80.12 | $70.29 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 9 |
| Target Price | ★ $129.57 | $99.67 |
| AVG Volume (30 Days) | 318.7K | ★ 941.7K |
| Earning Date | 03-04-2026 | 03-03-2026 |
| Dividend Yield | N/A | ★ 3.16% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.05 |
| Revenue | N/A | ★ $2,097,839,000.00 |
| Revenue This Year | $45.89 | $10.39 |
| Revenue Next Year | $30.17 | $3.91 |
| P/E Ratio | ★ N/A | $16.61 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $61.96 | $50.00 |
| 52 Week High | $138.70 | $87.00 |
| Indicator | BLLN | KTB |
|---|---|---|
| Relative Strength Index (RSI) | 54.69 | 54.62 |
| Support Level | $63.98 | $66.71 |
| Resistance Level | $86.01 | $72.31 |
| Average True Range (ATR) | 5.61 | 2.80 |
| MACD | 1.30 | -0.41 |
| Stochastic Oscillator | 75.47 | 35.51 |
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
Kontoor Brands Inc is a lifestyle apparel company. It designs, manufactures, procures, sells, and licenses apparel, footwear, and accessories, mainly under the brand names Wrangler, Lee, Helly Hansen, and a few other brands. The company also licenses the use of its brands in certain regions. Its products are sold through wholesale and direct-to-consumer channels in the United States (its key revenue-generating market) and internationally, mainly in Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Non-U.S. Americas regions. The company's three reportable segments are Wrangler, Lee, and Helly Hansen. The majority of its revenue is generated from the Wrangler segment, which offers denim, apparel, footwear, and accessories through Wrangler and various sub-brands.